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Interleukin (IL)-8-driven neutrophil inﬁltration of the gastricmucosa is pathognomonic of per-
sistent Helicobacter pylori infection. Our prior study showed that ectopic over-expression
of MUC1 in human AGS gastric epithelial cells reduced H. pylori -stimulated IL-8 produc-
tion compared with cells expressing MUC1 endogenously. Conversely, Muc1 knockout
(Muc1−/−) mice displayed an increased level of transcripts encoding the keratinocyte
chemoattractant (KC), the murine equivalent of human IL-8, in gastric mucosa compared
with Muc1+/+ mice during experimental H. pylori infection. The current study tested
the hypothesis that a decreased IL-8 level observed following MUC1 over-expression is
mediated through the ability of MUC1 to associate with β-catenin, thereby inhibiting H.
pylori -induced β-catenin nuclear translocation. Increased neutrophil inﬁltration of the gas-
tric mucosa of H. pylori -infected Muc1−/− mice was observed compared with Muc1+/+
wild type littermates, thus deﬁning the functional consequences of increased KC expres-
sion in the Muc1-null animals. Protein co-immunoprecipitation (co-IP) studies using lysates
of untreated or H. pylori -treated AGS cells demonstrated that (a) MUC1 formed a co-IP
complex with β-catenin and CagA, (b) MUC1 over-expression reduced CagA/β-catenin co-
IP, and (c) in the absence ofMUC1 over-expression, H. pylori infection increased the nuclear
level of β-catenin, (d) whereas MUC1 over-expression decreased bacteria-driven β-catenin
nuclear localization. These results suggest that manipulation of MUC1 expression in gas-
tric epithelia may be an effective therapeutic strategy to inhibit H. pylori -dependent IL-8
production, neutrophil inﬁltration, and stomach inﬂammation.
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INTRODUCTION
Stomach cancer is the fourth most common cancer worldwide and
the second most common cause of cancer death1 (∼800,000 per
year). In the U.S., 21,520 new cases of gastric cancer with 10,340
deaths are estimated to occur in 20112. Colonization of the gastric
mucosa by Helicobacter pylori is the strongest identiﬁed risk factor
for malignancies that arise within the stomach, with infection by
the bacteria estimated to cause ∼70% of all gastric cancers (Peek
et al., 2010). However, the vast majority of H. pylori-infected indi-
viduals are asymptomatic beyondhistologic inﬂammation.Within
the subset of bacteria-infected individuals who do display clinical
symptoms, epidemiologic, and pathologic studies have conﬁrmed
a progressive increase in disease symptomatology and severity
over several decades startingwith chronic inﬂammation (gastritis),
followed by the development of non-cancerous or precancerous
lesions, and ﬁnally gastric adenocarcinoma (Correa, 1995). The
current paradigm of H. pylori-induced gastric cancer proposes
that chronic and persistent gastritis during a lifetime of infec-
tion generates an environment awash with inﬂammatory media-
tors and signaling pathways that ultimately lead to tumorigenesis
1http://www.who.int/mediacentre/factsheets/fs297/en
2http://www.cancer.gov/cancertopics/types/stomach
(Correa and Piazuelo, 2011). Indeed, the host inﬂammatory
response to H. pylori infection is a primary factor involved in
the development of stomach cancer. In support of this hypoth-
esis, chronic stomach infection with H. pylori is associated with
epithelial cell gene mutations, inhibition of apoptosis, stimulation
of angiogenesis, and increased cell proliferation (MacFarlane and
Stover, 2007). Therefore, better understanding of host proinﬂam-
matory mechanisms, as well as the counter-regulatory pathways
that normally attenuate inﬂammation,will provide important new
information to treat H. pylori-infected patients with gastritis who
are at increased risk for developing gastric cancer.
Epithelial cells of the mucosa, including the gastric epithe-
lium, express multiple surface receptors that signal the presence
of mucosal pathogens and activate host inﬂammation (Brown
et al., 2010). While much is known concerning the inﬂamma-
tory pathways that are activated following microbial coloniza-
tion, relatively few studies have characterized the counterbal-
ancing anti-inﬂammatory responses. Using a mouse model of
H. pylori stomach infection, we recently reported that expres-
sion of the Mucin-1 (Muc1) protein counter-regulated H. pylori-
induced gastric inﬂammation (Guang et al., 2010). MUC1/Muc1
(by convention, MUC1 in humans, Muc1 in animals) is a mem-
brane bound protein with a highly glycosylated ectodomain and a
tyrosine phosphorylated intracellular domain that is expressed by
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all secretory epithelia and most hematopoietic cells. The MUC1
cytoplasmic region interacts with β-catenin through a -S-X-X-X-
X-X-S-S-L- motif (where X represents any amino acid) that is
conserved with other β-catenin-binding partners, including the
cadherins (Yamamoto et al., 1997; Li et al., 2001a; Schroeder
et al., 2003; Molock and Lillehoj, 2006). β-Catenin was origi-
nally identiﬁed in the Wnt signaling pathway, a major onco-
genic pathway associated with gastric tumorigenesis (Oshima and
Oshima,2010). Subsequently,β-cateninwas demonstrated to form
a multiprotein complex that anchors the cytoplasmic domain of
E-cadherin to the actin cytoskeleton, thereby regulating epithe-
lial barrier formation, the paracellular pathway, and polarity in
normal cells (Baum and Georgiou, 2011). However, the role of
MUC1/β-catenin interaction in regulating H. pylori gastritis is
unknown.
Helicobacter pylori express a number of virulence factors that
promote infection, including the cytotoxin-associated gene A
(CagA). Individuals infected with bacterial strains carrying the
Cag pathogenicity island (PAI) have a stronger gastric inﬂam-
matory response and are at a greater risk of developing stomach
cancer compared with individuals infected with strains lack-
ing the Cag PAI (Kusters et al., 2006). The Cag PAI encodes
a type IV secretion apparatus that delivers the CagA protein
into gastric epithelial cells where it disrupts the cytoskeleton,
modiﬁes intercellular adherence, and alters cell polarity (Back-
ert and Selbach, 2008). Recent mechanistic studies have begun
to elucidate how CagA manifests its numerous cellular effects
through the modiﬁcation of speciﬁc signal transduction pathways
(Hatakeyama, 2004). Among the intracellular signaling cascades
that are affected by CagA is the β-catenin pathway (Franco et al.,
2005; Bebb et al., 2006; Murata-Kamiya et al., 2007). For example,
Murata-Kamiya et al. (2007) reported that CagA formed a co-
immunoprecipitation complex with E-cadherin, thereby destabi-
lizing the E-cadherin/β-catenin complex and cytoplasmic/nuclear
accumulation of β-catenin. Because MUC1 interacts with β-
catenin (Li et al., 2001a), and because nuclear β-catenin trans-
activates the IL-8 gene promoter (Lévy et al., 2002), we hypoth-
esized that one of the mechanisms by which up-regulation of
MUC1 expression reduces H. pylori-stimulated IL-8 production
involves disruption of CagA-dependent β-catenin nuclear local-
ization. As an initial step toward testing this hypothesis, the
current study investigated protein–protein interactions between
MUC1, β-catenin, and CagA, and the cytoplasm/nuclear distrib-
ution of these proteins, in H. pylori-treated AGS gastric epithelial
cells.
MATERIALS AND METHODS
BACTERIA
Helicobacter pylori strains SS1 (Ding et al., 2009) and 26695
(Talarico et al., 2009) were maintained on Columbia blood agar
containing 7% deﬁbrinated horse blood (Cleveland Scientiﬁc,
Bath, OH, USA), 20μg/ml bacitracin, 20μg/ml trimethoprim,
16μg/ml cefsulodin, 6.0μg/ml vancomycin, and 2.5μg/ml fun-
gizone (Sigma, St. Louis, MO, USA) under microaerophilic con-
ditions as described (Ding et al., 2009). For in vitro infection of
AGS cells, bacteria were grown in static liquid cultures of Brucella
broth (Difco, Detroit, MI, USA) containing 10% heat inactivated
fetal bovine serum (FBS) and antibiotics at 37˚C with 10% CO2.
Muc1 KNOCKOUT MICE
Muc1−/− mice on a FVB genetic background were generated
by homologous recombination (Guang et al., 2010). Age- (8–
12week) and gender-matched FVB Muc1+/+ littermates were
from The Jackson Labs (Bar Harbor, ME, USA). Muc1 genotypes
and phenotypes were conﬁrmed by polymerase chain reaction and
Western blot analysis, respectively, using gastric epithelial tissues.
All mice were caged in Static Micro-Isolator LPTM cages (Lab
Products, Seaford,DE,USA), bedded in combination size corncob
bedding, fed solid chow, and housed under speciﬁc pathogen-free
conditions.
H. PYLORI STOMACH INFECTION AND HISTOLOGIC EVALUATION
Mice were infected by gastric intubation on two consecutive days
with 0.5ml of log-phase cultures of H.pylori strain SS1 at 1.0× 107
colony forming units (CFU)/animal as described (Guang et al.,
2010). Mice were sacriﬁced by intraperitoneal pentobarbital injec-
tion at 4weeks post-infection and stomach strips were ﬁxed in
K-2 ﬁxative (2% paraformaldehyde, 2.5% glutaraldehyde, 0.1M
sodium cacodylate buffer, 0.025% CaCl2) as described (Ding et al.,
2009). The ﬁxative was replaced with 0.1M sodium cacodylate
buffer (4˚C) containing sodium azide (pH 7.35–7.40). Tissue was
parafﬁn embedded and sectioned for analysis by Giemsa stain-
ing. Gastric inﬂammation was assessed as described (Stuller et al.,
2008). Brieﬂy, the area of the tissue section displaying the most
severe inﬂammation was evaluated blindly and assigned a global
score from 0 to 5 based on the following parameters: 0, absence
of lesions; 1, mild inﬁltrate of inﬂammatory cells, usually along
the base of the glands; 2, larger area of inﬂammation extending
between glands and/or in submucosa; 3, inﬂammatory inﬁltrate
extending between glands toward the lumen and in the underly-
ing submucosa; 4, intense transmucosal inﬂammation extending
across the ﬁeld, distorting glandular architecture, with epithelial
hyperplasia and extensive mucous cell metaplasia often present; 5,
extensive mucosal and submucosal inﬂammation with complete
disruption of glandular architecture and ulceration. All animal
procedures were approved by the Institutional Animal Care and
Use Committee at the University of Maryland.
AGS CELLS
AGS gastric adenocarcinoma cells (CRL-1739, ATCC, Manassas,
VA, USA) were cultured in DMEM/F12 medium containing 10%
FBS, 100 units/ml penicillin, and 100 μg/ml streptomycin (Invit-
rogen, Carlsbad, CA, USA). The cells were washed with PBS and
treated for 24 h with H. pylori strain 26695 at a multiplicity of
infection (MOI) of 100, or with PBS as a vehicle control.
OVER-EXPRESSION OF MUC1
AGScells in 60-mmdisheswere transfectedwith thepcDNAempty
vector (Invitrogen) or a MUC1 expression plasmid (pMUC1)
using Lipofectamine as described (Lillehoj et al., 2003). The cells
were cultured for 24 h with PBS or H. pylori, and processed for
co-immunoprecipitation.
CO-IMMUNOPRECIPITATION ASSAY
Helicobacter pylori-treated AGS cells were washed with PBS and
lysed at 4˚C with PBS, pH 7.2 containing 1.0% NP-40, 0.5%
sodium deoxycholate, 0.1% SDS, 10mM NaF, 1.0mM NaVO4,
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and 1.0% protease inhibitor cocktail (Sigma) as described (Guang
et al., 2010). Equal protein aliquots (1.0mg) were immunopre-
cipitated with 2.0μg of antibodies to MUC1, β-catenin, or H.
pylori CagA (Santa Cruz Biotechnology, Santa Cruz, CA, USA)
plus protein G-agarose (Invitrogen) as described (Lillehoj et al.,
2003). Immunoprecipitated proteins were resolved on 4–20%
SDS-polyacrylamide gels and transferred to PVDF membranes
(BioRad, Richmond, CA, USA). The membranes were blocked
for 1 h with PBS containing 0.1% Tween 20 (PBS-T) and 5%
non-fat dry milk (Sigma) and reacted with antibodies against
MUC1, β-catenin, or CagA, each diluted 1:1,000. The membranes
were washed with PBS-T, incubated for 1 h at room temperature
with horseradish peroxidase-conjugated anti-mouse IgG antibody
(Jackson ImmunoResearch Laboratories, West Grove, PA, USA)
diluted 1:5,000 and developed with enhanced chemiluminescence
substrate (Thermo Scientiﬁc, Rockford, IL, USA). To conﬁrm
equivalent protein loading and transfer, the blots were stripped
with 62.5mM Tris–HCl, pH 6.7, 100mM 2-mercaptoethanol, and
2.0%SDS,blockedwithPBS-T,5%milk, andprobedwith the same
antibody used for immunoprecipitation. Immunoreactive bands
were identiﬁed by co-migration of prestained protein size markers
(Fermentas, Glen Burnie, MD, USA). In some experiments, AGS
whole cell lysates, or cytoplasmic and nuclear fractions of the cells
(Guang et al., 2010), were directly probed with antibodies against
MUC1, β-catenin, or CagA followed by secondary antibodies and
chemiluminescence substrate. To control for protein loading and
transfer, the blots were stripped and reprobed for β-actin (Santa
Cruz Biotechnology).
CO-LOCALIZATION IMMUNOFLUORESCENCE MICROSCOPY
AGS cells were cultured overnight in 4-chamber Lab-Tek slides
(Nunc,Naperville, IL,USA), washed with PBS, treated for 5 h with
H. pylori, washed, and ﬁxed for 15min with 4% paraformalde-
hyde. The cells were permeabilized and blocked for 15min at 22˚C
with PBS containing 0.1% Triton X-100 and 5% normal goat
serum (NGS), followed by 15min at 22˚C with Image-iT™FX
signal enhancer (Invitrogen). The slides were washed and incu-
bated overnight at 4˚C with rabbit or mouse primary antibodies
to MUC1, β-catenin, or H. pylori CagA, all diluted 1/100 in PBS
containing 2% BSA, 2% NGS, and 0.05% Tween 20. The slides
were washed and incubated for 1 h at 22˚C with Alexa Fluor 488-
conjugated goat anti-rabbit IgG or Alexa Fluor 594-conjugated
goat anti-mouse IgG secondary antibodies (1/1,000; Invitrogen).
DAPI was used to counterstain nuclei. The cells were mounted
withVectashield (Vector Laboratories, Burlingame, CA, USA) and
visualized using an Axio Observer.Z1 microscope (Carl Zeiss,
Oberkochen, Germany) ﬁtted with a 63× objective and stan-
dard excitation/emission ﬁlters for detection of Alexa Fluor 488,
Alexa Fluor 594, and DAPI. Images were cropped and assembled
into panels with Adobe Photoshop 4.0 (Adobe Systems, San Jose,
CA, USA).
RESULTS
H. PYLORI -INFECTED Muc1−/− MICE HAVE INCREASED NEUTROPHIL
INFILTRATION IN THE GASTRIC MUCOSA COMPARED WITH Muc1+/+
MICE
Our prior study demonstrated that silencing of MUC1 expres-
sion in human gastric AGS epithelial cells using a MUC1-targeting
small interfering (si)RNA, or through defective Muc1 expression
in Muc1 knockout mice, increased H. pylori-stimulated IL-8 or
keratinocyte chemoattractant (KC) production compared with
the respective MUC1/Muc1-expressing cells (Guang et al., 2010).
Because IL-8 and KC are chemotactic for neutrophils, we asked
whether abrogation of Muc1 expression in a mouse model of H.
pylori infection similarly increased neutrophil inﬁltration of the
gastric mucosa. Muc1+/+ and Muc1−/− mice were challenged by
gastric intubation with 1.0× 107 CFU/animal of H. pylori, and
the gastric mucosa was visualized at 4 weeks post-infection by
Giemsa staining as described (Ding et al., 2009). Figure 1Ai–v
illustrates representative stomach sections from infected andunin-
fectedMuc1+/+ andMuc1−/− mice.Quantitative analysis revealed
no differences in neutrophilic inﬂammation between uninfected
Muc1+/+ and uninfected Muc1−/− mice (Figure 1B). By con-
trast, signiﬁcantly greater neutrophil inﬁltration of the gastric
mucosa was seen in H. pylori-infected Muc1−/− mice compared
with infected Muc1+/+ mice.
MUC1 FORMS A CO-IMMUNOPRECIPITATION COMPLEX WITH
β-CATENIN AND CagA
We and others have previously shown that MUC1 interacts with
several members of the Armadillo protein family, including β-
catenin and p120-catenin (Li et al., 2001a; Schroeder et al.,
2003; Molock and Lillehoj, 2006). In addition, H. pylori CagA is
known to destabilize the E-cadherin/β-catenin complex (Murata-
Kamiya et al., 2007), andCagAdirectly interacts with p120-catenin
(Oliveira et al., 2009). On the basis of these combined studies,
we hypothesized that the increased IL-8 and KC levels observed
with MUC1/Muc1 deﬁciency was mediated through the ability
of MUC1 mucin to associate with β-catenin and/or CagA. To
test this hypothesis, reciprocal co-immunoprecipitation (co-IP)
experiments were performed between the three denoted proteins
in lysates of AGS cells. MUC1 formed a co-IP complex with β-
catenin in untreated and H. pylori-treated AGS cells (Figure 2A).
Correspondingly, CagA formed a co-IP complex with MUC1
(Figure 2B) and with β-catenin (Figure 2C) in the infected cells.
As controls, total MUC1 and β-catenin protein levels were equal
in untreated and bacteria-treated cells (Figure 2D). Moreover, it
appeared that MUC1/β-catenin co-IP was increased in H. pylori-
treated cells comparedwith untreated cells (Figure 2A), suggesting
that CagA may release β-catenin from E-cadherin, thus allow-
ing it to bind to MUC1. By immunoﬂuorescence microscopy,
co-staining of H. pylori-infected AGS cells with antibodies to
MUC1 and β-catenin, and with antibodies to MUC1 and CagA,
demonstrated that these proteins are both found within the same
cellular compartment (Figures 3i–viii). By confocal microscopy,
co-localization of MUC1 with β-catenin (Figure 3ix), and MUC1
with CagA (Figure 3x), was also apparent.
OVER-EXPRESSION OF MUC1 REDUCES CagA/β-CATENIN co-IP
BecauseMUC1 interactedwith both β-catenin andCagA,we asked
whether over-expression of MUC1 would modulate the interac-
tion between the latter two proteins. AGS cells transfected with a
MUC1 expression plasmid, or with the empty vector control, were
processed for reciprocal β-catenin/CagA and CagA/β-catenin co-
IPs. As illustrated in Figure 4, reduced co-immunoprecipitation
between β-catenin and CagA was observed in MUC1-transfected
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FIGURE 1 | H. pylori -infected Muc1−/−mice have increased neutrophils
in the gastric mucosa compared with Muc1+/+ mice. (A) Muc1+/+ (i,iii) and
Muc1−/− (ii,iv) mice were uninfected (i,ii) or were infected with H. pylori
(iii,iv), and gastric mucosa were assessed at 4weeks post-infection by
Giemsa staining. Arrows indicate inﬂammatory cell inﬁltrates. Original
magniﬁcation, 200×. (v) Illustrates a higher magniﬁcation of the indicated
area of (iv) to demonstrate the inﬁltrating cells. (B) Quantitative analysis of
gastric inﬂammation on a scale of 0–5 based on the following parameters: 0,
no signiﬁcant lesions; 1, mild inﬁltrate of inﬂammatory cells; 2, larger focus of
inﬂammation extending between glands and/or in submucosa; 3, patches of
inﬂammation extending between glands toward the lumen and in the
underlying submucosa; 4, intense transmucosal inﬂammatory inﬁltrate
extending across the ﬁeld distorting glandular architecture; 5, extensive
mucosal and submucosal inﬂammation with disruption of glandular
architecture and ulceration (Stuller et al., 2008). Each symbol represents an
individual tissue section. Horizontal bars represent median values.
Differences between median values were assessed by the Student’s t test.
The results are representative of two experiments.
cells compared with the empty vector controls, suggesting that
MUC1 competes with CagA for binding of β-catenin. Stripping
and reprobing these blots with the immunoprecipitating anti-
body conﬁrmed equal gel loading and membrane transfer of the
proteins in MUC1 and vector only transfected cells.
OVER-EXPRESSION OF MUC1 INHIBITS H. PYLORI -DEPENDENT
INCREASED NUCLEAR β-CATENIN LEVELS
Published studies have demonstrated that H. pylori infection
of gastric epithelia increases nuclear translocation of β-catenin
(Murata-Kamiya et al., 2007). Given that MUC1 formed a co-IP
complex with β-catenin in the cytoplasm of AGS cells (Figure 2A),
we hypothesized that over-expression of MUC1 would inhibit
the ability of H. pylori to induce β-catenin nuclear transloca-
tion. In untreated cells transfected with the pcDNA empty vector,
or with the pMUC1 expression plasmid, β-catenin levels in the
nucleus were generally less than or relatively equal to cytoplas-
mic β-catenin levels (Figure 5, lanes 1 vs. 2 and 3 vs. 4). In H.
pylori-treated cells transfected with the empty vector, the level of
nuclear β-catenin was increased compared with the cytoplasmic
β-catenin level (lanes 6 vs. 5), thus corroborating prior reports
(Murata-Kamiya et al., 2007). However, in bacteria-treated cells
that were over-expressing MUC1, the level of nuclear β-catenin
was dramatically reduced compared with cytoplasmic β-catenin
(lanes 8 vs. 7). In contrast, while MUC1 also translocated to the
nucleus to a small extent compared with its cytoplasmic level,
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FIGURE 2 | Co-immunoprecipitation of MUC1, β-catenin, and H. pylori
CagA. (A–C) AGS cells were untreated or were treated with H. pylori (Hp)
at an MOI of 100. At 24 h post-infection, the cells were washed and cell
lysates were immunoprecipitated with the indicated antibodies.
Immunoprecipitated proteins were resolved by SDS-PAGE, transferred to
PVDF membranes, and processed for immunoblotting with the indicated
antibodies. (D) Lysates of untreated or HP-treated AGS cells were resolved
by SDS-PAGE, transferred to PVDF membranes, and processed for
immunoblotting with antibodies to MUC1, β-catenin, CagA, or β-actin.
Molecular weight markers are indicated on the left in kilodaltons (kDa). The
results are representative of two experiments.
cytoplasmic and nuclear MUC1 levels were relatively equal in
untreated and H. pylori-treated cells (lanes 11 vs. 15 and 12 vs. 16).
The distribution of CagA between the cytoplasmic and nuclear
fractions was unaffected by manipulation of MUC1 expression
(lanes 21 vs. 23 and 22 vs. 24). Indeed, the relative distribution of
β-catenin in the cytoplasmic and nuclear fractions of H. pylori-
treated cells that were over-expressing MUC1 (lanes 7, 8) was
similar to that seen with MUC1 (lanes 15, 16) and quite distinct
from that observed with CagA (lanes 23, 24). In summary, these
data are consistent with the hypothesis that over-expression of
MUC1 blocks H. pylori-dependent β-catenin nuclear transloca-
tion, likely through sequestration of the MUC1/β-catenin protein
complex in the cytoplasm.
DISCUSSION
This study demonstrated (a) increased neutrophil inﬁltration of
the gastric mucosa of H. pylori-infected Muc1−/− mice compared
with Muc1+/+ littermates, (b) MUC1/β-catenin, MUC1/CagA,
and CagA/β-catenin co-IPs complexes in lysates of AGS cells, (c)
reduced level of the CagA/β-catenin co-IP complex in MUC1
FIGURE 3 | Co-localization microscopy of MUC1, β-catenin, and
H. pylori CagA. AGS cells were treated with H. pylori and stained with (A)
MUC1 (i) and β-catenin (ii) antibodies, or with (B) MUC1 (iii) and CagA (iv)
antibodies. The cells were counterstained with DAPI (v,vi) and examined by
immunoﬂuorescence microscopy. Co-localization of MUC1 with β-catenin
(vii), and MUC1 with CagA (viii), was revealed by yellow immunostaining
of merged images. Co-localization of MUC1 with β-catenin (ix), and MUC1
with CagA (x) was also revealed by confocal microscopy along the z -axis of
the cell monolayers, with the apical region of the cells facing up. Arrows in
(ix,x) indicate areas of co-localization. Scale bar, 25μm.The results are
representative of two experiments.
over-expressing cells, (d) increased nuclear level of β-catenin
in H. pylori-infected cells, and (e) inhibition of bacteria-driven
nuclear β-catenin following MUC1 over-expression. These results,
togetherwithourprior data (Guang et al.,2010),canbemost parsi-
moniously explained if over-expression of MUC1blocksH. pylori-
stimulated β-catenin nuclear translocation, thereby attenuating
IL-8 production and neutrophil gastric inﬁltration. A schematic
illustration of the putative mechanisms and pathways involving
β-catenin and CagA in H. pylori-infected gastric epithelial cells
with or without MUC1 over-expression with regards to the pre-
dominant protein complexes, nuclear translocation of β-catenin,
and IL-8 production is shown in Figure 6.
Helicobacter pylori colonize the gastric mucosa of up to half the
world’s population and play a causative role in the development
of gastritis, peptic ulcers, and stomach cancer. While H. pylori
infection causes a massive inﬂux of neutrophils into the stomach
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FIGURE 4 | Over-expression of MUC1 reduces CagA/β-catenin
co-immunoprecipitation. AGS cells were transfected with the pcDNA
empty vector or the pMUC1 expression plasmid. At 24 h post-transfection,
the cells were untreated or were treated with H. pylori (Hp) at an MOI of
100. At 24 h post-infection, the cells were washed and cell lysates were
immunoprecipitated with antibodies to β-catenin (A) or CagA (B).
Immunoprecipitated proteins were resolved by SDS-PAGE, transferred to
PVDF membranes, and processed for immunoblotting with antibodies to
CagA (A) or β-catenin (B). To control for to control for protein loading and
transfer, blots were stripped and reprobed with the same antibody used for
immunoprecipitation. Molecular weight markers are indicated on the left in
kilodaltons (kDa). (C) Densitometry of the blots in (A). (D) Densitometry of
the blots in (B). Each bar represents the mean±SEM value of the density
of the CagA band normalized to the β-catenin band [from (A)], or the
β-catenin band normalized to the CagA band [from (B)], in Hp-treated cells
(n = 3). (E) Increased MUC1 expression in AGS cells transfected with the
pMUC1 plasmid. The results are representative of two experiments.
epithelium, for unknown reasons, the host immune response
does not clear the infection. Up to 70% of H. pylori strains
in Western countries encode the Cag PAI (Peek and Crabtree,
2006). Individuals infected with Cag PAI expressing H. pylori
strains have greater gastric inﬂammatory responses and are at
an increases risk of developing peptic ulcers or stomach cancer
than those infected with strains lacking the Cag PAI (Kusters
et al., 2006). Following adhesion of H. pylori to gastric epithe-
lial cells, the type IV secretion system expressed by the Cag PAI
delivers several bacterial components to the cell cytosol. Among
these are bacterial peptidoglycan and the CagA gene product. Pep-
tidoglycan is an agonist for the innate immune receptor, Nod1,
which stimulates expression of TNF-α and IL-8, as well as other
cytokines and chemokines, that promote inﬂammation (Viala
et al., 2004).
FIGURE 5 | MUC1 over-expression inhibits H. pylori -dependent
increased nuclear β-catenin level. AGS cells were transfected with the
pcDNA empty vector or the pMUC1 expression plasmid. At 24 h
post-transfection, the cells were untreated or were treated with H. pylori
(Hp) at an MOI of 100. At 24 h post-infection, the cells were washed,
cytoplasmic (Cy) and nuclear (Nu) lysate fractions were prepared, and
immunoprecipitated with antibodies to β-catenin (lanes 1–8), MUC1 (lanes
9–16), or CagA (lanes 17–24). To control for to control for protein loading and
transfer, blots were stripped and reprobed with antibody to β-actin.
Molecular weight markers are indicated on the left in kilodaltons (kDa). The
results are representative of two experiments.
CagA elicits multiple cellular alterations, including disruption
of the cytoskeleton, increased intercellular adhesion, altered intra-
cellular signaling, and loss of cell polarity (Backert and Selbach,
2008). Some of these effects occur as a consequence of CagA phos-
phorylation at a C-terminal EPIYA-repeat motif by the c-Src and
Abl cytosolic tyrosine kinases, resulting in activation of the protein
tyrosine phosphatase, SHP-2 (Hatakeyama, 2004). Cag+ strains of
H. pylori also have been shown to activate the receptor protein
tyrosine kinase, epidermal growth factor receptor (EGFR; Keates
et al., 2005), although in this case themechanismhas been reported
to involve activation of toll-like receptor (TLR)4 by the H. pylori
secretory protein,HP0175 (Basu et al., 2008). As with activation of
SHP-2, activation of EGFR by H. pylori is associated with altered
signal transduction and gene expression in host epithelial cells
that may contribute to pathogenesis. In this regard, EGFR tyro-
sine phosphorylates the MUC1 intracellular domain, leading to
binding of β-catenin (Li et al., 2001b). Interaction of MUC1 with
β-catenin modulated the Wnt target gene, cyclin D1, in H. pylori-
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FIGURE 6 | Schematic illustration depicting the putative
interactions between MUC1, β-catenin, and CagA in H.
pylori -infected gastric epithelial cells. (A)Without MUC1
over-expression, CagA delivered to the cytosol of H. pylori (Hp)-infected
cells displaces β-catenin (β) from E-cadherin (E-cad), allowing β-catenin
to translocate to the nucleus and activate IL-8 gene expression. (B)
With MUC1 over-expression, β-catenin that is displaced by CagA binds
to MUC1 (i), thus blocking its nuclear translocation and attenuating IL-8
production. CagA also binds to MUC1, possibly either without (ii) or
with (iii) β-catenin.
induced gastric cancer (Udhayakumar et al., 2007) and decreased
nuclear translocation of β-catenin in a human embryonic kidney
cell model system (Lillehoj et al., 2007).
Previous studies have identiﬁed H. pylori-induced CagA-
dependent and CagA-independent β-catenin activation and
nuclear translocation (Franco et al., 2005; Bebb et al., 2006;
Murata-Kamiya et al., 2007; Weydig et al., 2007). In the nucleus,
β-catenin acts as a transcription factor in association with the lym-
phoid enhancer-binding factor/T cell factor (LEF/TCF) proteins
(Henderson and Fagotto, 2002). Among the best characterized tar-
get genes activated by β-catenin/LEF/TCF complexes are cyclinD1,
c-Myc, and others that promote carcinogenesis by stimulating cell
proliferation and inhibiting apoptosis. In addition, evidence exists
to demonstrate that nuclear β-catenin stimulates the expression of
a variety of inﬂammation-related genes, including IL-8. For exam-
ple, Lévy et al. (2002) reported that the β-catenin/TCF4 complex
transcriptionally activated IL-8 gene expression, and that ectopic
expression of β-catenin in hepatoma cells increased IL-8 protein
secretion. IL-8 also has been identiﬁed as a transcriptional target of
β-catenin in humanumbilical vein endothelial cells (Masckauchán
et al., 2005). Comparison of disease and healthy tissues in a mouse
model of colorectal cancer identiﬁed KC (murine IL-8) as a major
up-regulated proinﬂammatory chemokine in colon cancer (Zhu
et al., 2011). Finally, translocation of β-catenin into the nucleus of
hepatocellular carcinoma cells was correlated with increased IL-8
production (Lai et al., 2011). In the current study, itmaybepossible
that up-regulation of MUC1 expression in AGS gastric epithelial
cells blocks H. pylori-dependent β-catenin activation and nuclear
translocation, thereby inhibiting bacteria-induced IL-8 produc-
tion. This remains a valid hypothesis for future testing. Infection
of cells with suppressed β-catenin expression by CagA-positive
and CagA-negative H. pylori, followed by quantiﬁcation of IL-8
production would start to address this question and would greatly
expand the physiological relevance of these ﬁndings.
In addition to binding to MUC1, β-catenin also formed a co-IP
complex with CagA (Figure 2C). Similarly, MUC1/CagA protein
interaction was observed (Figure 2B), suggesting that CagA may
indirectly associatewithβ-catenin through theirmutual binding to
MUC1. Our previous study demonstrated that MUC1 interacted
with β-catenin, but not with γ-catenin, in transfected HEK293
cells (Molock and Lillehoj, 2006). MUC1 contains a -S-A-G-N-
G-G-S-S-L- sequence that serves as the binding site for β-catenin
and that ﬁts a canonical β-catenin-binding motif present in E-
cadherin. E-cadherin also binds to γ-catenin and mapping studies
have shown that β- and γ-catenin harbor overlapping binding sites
on E-cadherin (Potter et al., 1999). Binding of the two catenins to
E-cadherin is mutually exclusive. Because the β- and γ-catenin
binding sites on E-cadherin are only partially overlapping, it is
possible that additional sequences outside of the denoted motif,
and not present in MUC1, may contribute to γ-catenin binding.
In summary, the results of this study raise the interesting
prospect of counteractingH. pylori-induced IL-8 production,with
subsequent reduction of neutrophil inﬁltration and gastritis, using
therapeutic strategies to augment MUC1 expression in the gas-
tric mucosa. Future investigations of the potential of augmented
MUC1 expression for treatment of H. pylori gastritis may yield
promising results.
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